Merel Ritskes member of the - 3RCC Scientific Advisory Board

8 August 2018

The 3RCC Scientific Advisory Board (SAB) is responsible for providing scientific expertise to the 3RCC, evaluating grant applications and evaluating the progress and functioning of the center. The 3RCC SAB is composed of internationally recognized experts on 3Rs having expertise on 3Rs.

On the 27 March 2018, the Swiss 3R Competence Centre (3RCC) was founded to promote the principles of 3R in the areas of research and education. It represents an association of academia, industry, regulators, government and animal welfare association including eleven Higher Education Institutions from Switzerland, the Swiss association of pharmaceutical industry (Interpharma), the Swiss Federal Food Safety and Veterinary Office (FSVO) and, the Swiss Animal Protection. The 3RCC also benefits from the support from the Swiss State Secretariat for Education, Research and Innovation (SERI), as it represents a scientific centre of national importance working on a non-commercial basis according to article 15 of the Federal Act on the Promotion of Research and Innovation (RIPA).

Situated in Bern, the 3RCC’s objectives are to:

Promote research by subsidizing scientific projects of high quality and care for animals;
Develop an educational strategy targeted at different educational programs; and
Build a professional communication capacity available for all stakeholders interested in animal experimentation and 3Rs.

In addition, the 3RCC will be responsible for monitoring the progress made regarding the implementation of the principles of 3Rs in Switzerland.

Merel Ritskes is a member of the theme Reconstructive and regenerative medicine.

Want to know more about these subjects? Click on the buttons below for more news.

RIHS Health Evidence Research Reconstructive and regenerative medicine

Related news items

Regional hospitals invest in joint research Four new projects have been granted

29 October 2020

Four more research projects have been granted in the promotion fund of the Radboudumc and the regional hospitals.

Two studies show potential of trained immunity for the treatment of cancer Radboudumc makes Cell twice in one issue

29 October 2020

Mihai Netea: "These studies show that stimulating trained immunity can have an important anti-cancer effect. In combination with current immunotherapy with 'checkpoint inhibitors', boosting trained immunity has the potential to significantly improve cancer treatment"

RIMLSpeaks Recognition & Rewards

29 October 2020

The annual RIMLSpeaks session on the topic of recognition and rewarding was organized on 14 October with guest speakers Rianne Letschert and Rita Struhkamp.

Research should facilitate discontinuation of antidepressants

29 October 2020

How do you reduce the use of antidepressants safely and without major problems? That is a question that concerns many patients and physicians. Radboudumc and Amsterdam UMC in the Netherlands are going to investigate this with a ZonMw grant of 1.5 million euros.

Cum Laude PhD defense for Vincent Aengevaeren

29 October 2020

We congratulate Vincent Aengevaeren! After defending his thesis entitled: ‘Potential Detrimental Effects of Exercise on the Heart’ on 28 October, Vincent attained his PhD degree with honors. Vincent had been appointed on a RIHS Junior Researcher grant.

Polyisocyanide Hydrogels as a Tunable Platform for Mammary Gland Organoid Formation

28 October 2020

A multidisciplinary team of RIMLS and Radboud University researchers published in Advanced Science that Polyisocyanide Hydrogels as a Tunable Platform for Mammary Gland Organoid Formation.